跳至主要内容
临床试验/ACTRN12612001027808
ACTRN12612001027808尚未招募3 期

Investigation into the Acute and Chronic Effects of Longvida Curcumin on Cognitive Function, Mood and Biomarkers of Health in a Cognitively Healthy Elderly Population Compared to an Elderly Population with Cognitive Decline

Swinburne University of Technology, Centre for Human Psychopharmacology0 个研究点目标入组 60 人开始时间: 2012年9月24日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
65 Years 至 80 Years(—)
性别
All

入选标准

  • 1. Male or female.
  • 2. Aged 65-80 years.
  • 3. Willing and able to provide written informed consent.
  • 4. Understands and is willing and able to comply with all study procedures.
  • 5. Free from history of stroke, other neurological conditions (e.g. Parkinsons, epilepsy), depression, psychiatric disorders, low base line intellect, alcohol abuse past / present.
  • 6. Cognitively healthy participants must be free from any form of cognitive impairment. For the cognitively declined particpants, participants must have objective memory impairment for age and education level.
  • 7. Free from dementia.
  • 8. English speaking.
  • 9. Must have normal or corrected vision.
  • 10. Free from other medical conditions which may affect ability to participate in the study
  • 11. Participants taking part in study Stage Two must be right handed

排除标准

  • 1. Any significant concurrent illness including any auto-immune disorder, bleeding disorders, heart conditions, diabetes, glaucoma, high blood pressure or osteoporosis.
  • 2. Any known or suspected food allergies
  • 3. Smokers and users of recreational drugs (except alcohol and other food grade actives).
  • 4. Have participated in any other study involving an investigational product in the last 4 weeks.
  • 5. Taking any of the following: anti-coagulant drugs (Warfarin,Heparin, Plavix); anti-cholinergics or acetylcholinesterase inhibitors: bethanechol (Ureholine), donepezil (Aricept),
  • 6. Taking steroid medications
  • 7. Taking vitamins or herbal supplements regularly
  • 8. Left-handed participants will be ineligible to take part in Stage Two

研究者

发起方
Swinburne University of Technology, Centre for Human Psychopharmacology

相似试验